These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14482852)

  • 1. A comparison of the myotrophic and androgenic activities of the phenylpropionates and decanoates of testosterone and nandrolone.
    OVERBEEK GA; de VISSER
    Acta Endocrinol (Copenh); 1961 Oct; 38():285-92. PubMed ID: 14482852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nitrogen metabolism and urinary androgens after loading with norandrostenolone decanoate].
    MARRAMA P; LAPICCIRELLA R; FERRARI C; BONATI B
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13(6)Suppl():1-11. PubMed ID: 14470178
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of myotrophic and androgenic activities of 19-nortestosterone cyclopentylpropionate, androstanolone, and methylandrostenediol.
    BARNES LE; STAFFORD RO; GUILD ME; OLSON KJ
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):35-8. PubMed ID: 13224668
    [No Abstract]   [Full Text] [Related]  

  • 4. The myotrophic and androgenic effects of 17-ethyl-19-nortestosterone and related compounds.
    SAUNDERS FJ; DRILL VA
    Endocrinology; 1956 May; 58(5):567-72. PubMed ID: 13317831
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled evaluation of hemodialysis patients on nandrolone decanoate (ND) vs testosterone enanthate (TE) (Androgens and dialysis patient).
    Mirahmadi MK; Vaziri ND; Gorman JT
    Trans Am Soc Artif Intern Organs; 1979; 25():449-54. PubMed ID: 524621
    [No Abstract]   [Full Text] [Related]  

  • 6. Norandrostenolone phenylpropionate and norandrostenolone decanoate in the treatment of metastasizing mammary carcinoma.
    HORTLING H; MALMIO K; HIISI-BRUMMER L
    Acta Endocrinol Suppl (Copenh); 1961; (Suppl 63)():132-42. PubMed ID: 14449065
    [No Abstract]   [Full Text] [Related]  

  • 7. Norandrostenolone decanoate-a new anabolic steroid with prolonged effect. Some clinical observations.
    KALLIOMAKI JL; MARKKANEN TK; PIRILA AM; RUIKKA I
    Ann Med Intern Fenn; 1961; 50():177-84. PubMed ID: 14453337
    [No Abstract]   [Full Text] [Related]  

  • 8. [19-Norandrostenolone-decanoate (NAD) in the treatment of advanced genital cancer in the female].
    ADLER U
    Praxis; 1961 Sep; 50():956-8. PubMed ID: 13859454
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of norandrostenolone phenylpropionate].
    VAN OS H; DEMEULEMEESTER J
    Bull Soc Sci Med Grand Duche Luxemb; 1959 Oct; 96():287-307. PubMed ID: 13841117
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the anabolic action of 19-nortestosterone phenylpropionate. Preliminary note].
    de SALCEDO ; BORGES F; GODINHO P
    J Med (Oporto); 1960 Nov; 43():599-600. PubMed ID: 13831238
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of norandrostenolone phenylpropionate on the riboflavin content of blood.
    MARKKANEN T
    Ann Med Intern Fenn; 1962; 51():125-7. PubMed ID: 14469994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary clinical trials with the phenylpropionate of norandrostenolone (PPNA) as a protein anabolizing agent].
    HUGUENARD P; GODARD H
    Therapie; 1959; 14():738-44. PubMed ID: 14403896
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of norandrostenolone phenylpropionate (N.A.P.P.) in experimental tumorization].
    VERNE J; ROTH PC
    Bull Assoc Fr Etud Cancer; 1961; 48():535-7. PubMed ID: 13925515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of norandrosterolone phenylpropionate (durabolin) in growth retardation in children].
    BARTA ; CSERE M; NABRADY J
    Gyermekgyogyaszat; 1960 Sep; 11():262-8. PubMed ID: 14448494
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
    MALMIO K; HISI-BRUMMER L; HORTLING H
    Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of norandrostenolone phenylpropionate in psychiatric therapy].
    BOITTELLE G; BOITTELLE-LENTULO C; DUMEZIL C
    Ann Med Psychol (Paris); 1962 Feb; 120(1)():389-92. PubMed ID: 13870704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Favorable influence of 19-norandrostenolone phenylpropionate on the diabetic retinopathy].
    VALK LE
    Bull Mem Soc Fr Ophtalmol; 1959; 72():596-608. PubMed ID: 13840861
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
    de SALCEDO ; SOUSA CG
    J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.